vimarsana.com
Home
Live Updates
US FDA approves Pfizer's next-generation pneumococcal vaccin
US FDA approves Pfizer's next-generation pneumococcal vaccin
US FDA approves Pfizer's next-generation pneumococcal vaccine
The U.S. Food and Drug Administration has approved Pfizer Inc's next-generation vaccine to prevent pneumococcal disease in children aged six weeks to 17 years, the company said late on Thursday.... | April 28, 2023
Related Keywords
United States ,
Bengaluru ,
Karnataka ,
India ,
Sriparna Roy ,
Subhranshu Sahu ,
Disease Control ,
Pfizer ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
The ,
Wood ,
End ,
Drug ,
Administration ,
Gas ,
Approved ,
Vaccine ,
O ,
Prevent ,
Pneumococcal ,
Disease ,
N ,
Children ,
Ged ,
Six ,
Eeks ,
7 ,
Company ,
Aid ,
Gate ,
N Pfe Us7170811035 ,